Moss A J
Department of Medicine, University of Rochester School of Medicine and Dentistry, NY.
Cardiovasc Drugs Ther. 1990 Jun;4(3):665-7. doi: 10.1007/BF01856552.
This review discusses the substrate and triggers of ventricular tachyarrhythmias or fibrillation and highlights the concepts that underlie risk stratification. Topics covered include the risks posed by arrhythmias in patients with: a) postinfarction, b) cardiomyopathy c) mitral valve prolapse, d) Wolff-Parkinson-White syndrome, and e) the long QT syndrome. Appropriate identification of patients at high risk for malignant ventricular arrhythmias requires subclassification by disease entity, historic information about syncopal episodes, noninvasive testing, and invasive electrophysiologic studies in selected patients.
本综述讨论了室性快速性心律失常或颤动的底物和触发因素,并强调了风险分层背后的概念。涵盖的主题包括心律失常给以下患者带来的风险:a) 心肌梗死后,b) 心肌病,c) 二尖瓣脱垂,d) 预激综合征,以及e) 长QT综合征。要正确识别恶性室性心律失常的高危患者,需要按疾病实体进行亚分类,了解晕厥发作的病史信息,进行非侵入性检查,并对选定患者进行侵入性电生理研究。